|
End-of-day quote
Shanghai S.E.
17/08/2026
|
5-day change | 1st Jan Change | ||
| 15.36 CNY | +0.20% |
|
-1.73% | +1.92% |
| 08-11 | Tasly Pharmaceutical Appoints Chair | MT |
| 07-20 | Tasly Pharmaceutical Gets China Greenlight for Stroke Drug Trial | MT |
| Market Cap | 22.95B 3.4B 2.94B 2.76B 2.51B 4.72B 325B 4.79B 32.32B 12.66B 163B 12.78B 12.5B 542B | P/E 2026 * |
17.1x | P/E 2027 * | 14.3x |
|---|---|---|---|---|---|
| Enterprise Value | 21.69B 3.22B 2.78B 2.61B 2.37B 4.46B 308B 4.52B 30.55B 11.97B 154B 12.08B 11.82B 513B | EV / Sales 2026 * |
2.41x | EV / Sales 2027 * | 1.75x |
| Free-Float |
47.15% | Yield 2026 * |
2.93% | Yield 2027 * | 3.34% |
| 1 day | +0.20% | ||
| 1 week | -1.73% | ||
| Current month | -4.71% | ||
| 1 month | -0.13% | ||
| 3 months | +4.92% | ||
| 6 months | +4.70% | ||
| Current year | +1.92% |
| 1 week | 14.99 |  | 15.64 |
| 1 month | 14.99 | | 16.24 |
| Current year | 12.9 | | 16.24 |
| 1 year | 12.9 | | 17.69 |
| 3 years | 12.24 | | 18 |
| 5 years | 9.2 | | 18 |
| 10 years | 9.2 | | 34.22 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jin Yong Cai
CEO | Chief Executive Officer | 54 | 07/05/2024 |
Jie Wei
DFI | Director of Finance/CFO | 49 | 08/07/2018 |
Xin Yang
CIO | Chief Investment Officer | 45 | 30/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Ai Jian Wang
BRD | Director/Board Member | 72 | 01/06/2021 |
Jin Yong Cai
CHM | Chairman | 54 | 09/08/2026 |
Ke Xin Li
BRD | Director/Board Member | 58 | 07/05/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.20% | -1.73% | -5.07% | +11.71% | 3.4B | |
| -0.46% | -2.72% | -11.01% | -6.51% | 13.18B | |
| -0.16% | -2.78% | -32.52% | -58.08% | 4.97B | |
| -0.81% | -4.74% | +2.32% | -1.96% | 4.88B | |
| +0.29% | +0.71% | +7.12% | -27.92% | 4.22B | |
| -0.03% | -2.82% | -18.37% | +0.19% | 3.57B | |
| -1.06% | -6.33% | -8.56% | -10.25% | 3.32B | |
| +1.19% | +1.45% | -12.60% | -15.66% | 2.52B | |
| 0.00% | +10.60% | +3.45% | -10.61% | 1.81B | |
| -0.10% | -1.30% | -27.32% | -15.22% | 1.73B | |
| Average | -0.09% | -0.28% | -10.26% | -13.43% | 4.36B | |
| Weighted average by Cap. | -0.22% | -1.28% | -10.31% | -13.31% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 9B 1.33B 1.15B 1.08B 985M 1.85B 128B 1.88B 12.67B 4.97B 63.94B 5.01B 4.9B 213B | 9.78B 1.45B 1.25B 1.18B 1.07B 2.01B 139B 2.04B 13.78B 5.4B 69.53B 5.45B 5.33B 231B |
| Net income | 1.36B 202M 174M 164M 149M 280M 19.31B 284M 1.92B 751M 9.67B 758M 742M 32.18B | 1.61B 239M 206M 193M 176M 331M 22.81B 335M 2.26B 888M 11.43B 896M 876M 38.01B |
| Net Debt | -1.26B -187M -161M -151M -138M -259M -17.86B -263M -1.77B -695M -8.95B -701M -686M -29.76B | -5.78B -857M -740M -694M -632M -1.19B -81.93B -1.21B -8.14B -3.19B -41.05B -3.22B -3.15B -137B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/08/26 | CN¥15.36 | +0.20% | 15,244,484 |
| 14/08/26 | CN¥15.33 | -0.65% | 12,501,709 |
| 13/08/26 | CN¥15.43 | +0.78% | 17,154,509 |
| 12/08/26 | CN¥15.31 | -1.42% | 17,591,043 |
| 11/08/26 | CN¥15.53 | -0.64% | 19,133,296 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 600535 Stock
Select your edition
All financial news and data tailored to specific country editions
